Our technologies facilitate high throughput, precise analyte quantitation and multiplexing. One day our approach will make random access to broad test panels created on-demand on instrument systems placed across the bioanalytical application space a reality.
For instance, on the spot doctors will be able to select tests from a broad menu and combine them into panels of interest in the respective clinical context. Our research products are designed to provide smooth transfer of developed laboratory assays onto a cutting-edge point-of-care platform.
BLINK’s product platforms are designed to serve the scientific community through an Open Access development model.
The BLINK assay development model is accessible for both academic and commercial test developers, providing unprecedented freedom and flexibility to create new assays and reach new markets.
Developers can create complete products for research or diagnostics by combining their analyte specific reagents with the generic modules of the BLINK technology package. Of course, individual modules can also be integrated into existing workflows or lab automation solutions.